Navigation Links
The Pancreatic Cancer Action Network Announces Its 2008 Research Grant Awards Totaling Over $1 Million in New Research Funding
Date:4/15/2008

Among the 11 Awards Presented is the Inaugural Randy Pausch, PhD Pilot

Grant

EL SEGUNDO, Calif., April 15 /PRNewswire/ -- The Pancreatic Cancer Action Network (http://www.pancan.org) announced today the 2008 Research Grant Awards recipients who will dedicate their time to pancreatic cancer research. The grant portfolio, topping $1 million in new grants, includes four Pilot Grants, six Career Development Awards and one Fellowship Award. Collectively, these grants support junior and senior scientists and provide funding for research in diverse fields of inquiry, including: the origin and causes of pancreatic cancer; the biology of the disease, including underlying physiological and biochemical processes; detection, staging, and diagnosis; and novel therapeutic strategies.

The Pancreatic Cancer Action Network grants program is administered in partnership with the American Association for Cancer Research (AACR). This partnership utilizes the rigorous and well developed AACR peer review system ensuring that the very best science in the country is supported.

Among this year's Pilot Grants is one honoring Carnegie Mellon University Professor Dr. Randy Pausch, who is dying from pancreatic cancer and whose last lecture reflecting life's lessons became an internet sensation. The 2008 Randy Pausch, PhD - Pancreatic Cancer Action Network - AACR Pilot Grant was awarded to Nabeel Bardeesy, PhD from Massachusetts General Hospital, Boston.

"We are excited to announce the 2008 Research Grant Awards recipients and to honor our dear friend, Dr. Randy Pausch," stated Julie Fleshman, President and CEO of the Pancreatic Cancer Action Network. "These awards demonstrate the importance we place on expanding research and building a cadre of scientists committed to advancing the detection, diagnosis and treatment of pancreatic cancer."

The Research Grant Awards details and recipients are as follows:

Fellowship Award: One-year grant totaling $45,000 that is awarded to a postdoctoral or clinical research fellow at an academic facility, teaching hospital or research institution who is sponsored by a mentor.

Ken-Tye Yong, PhD -- State University of New York, Buffalo

Samuel Stroum - Pancreatic Cancer Action Network - AACR Fellowship

Award

Engineering Multimodal Targeted Probes for Pancreatic Cancer Detection

Career Development Awards: Two-year grants totaling $100,000 per award that are provided to junior faculty at academic and medical institutions.

Marie-Christine Daniel, PhD -- University of Maryland, Baltimore

County

Pancreatic Cancer Action Network - AACR Career Development Award

Multifunctional Nanovectors for Pancreatic Cancer Therapy

David W. Dawson, MD, PhD -- University of California, Los Angeles

Seena Magowitz - Pancreatic Cancer Action Network - AACR Career

Development Award

Wnt Signaling in Pancreatic Cancer Progenitor Cells

Joseph Michael Herman, MD -- Johns Hopkins University School of

Medicine, Baltimore

Blum-Kovler - Pancreatic Cancer Action Network - AACR Career

Development Award

Evaluation of Focused Radiation to Enhance the Impact of a Pancreatic

GM-CSF Vaccine

Hyunki Kim, PhD -- The University of Alabama at Birmingham

Skip Viragh - Pancreatic Cancer Action Network - AACR Career

Development Award

MRI to Monitor Early Pancreatic Tumor Response to a Novel Triple

Therapy

Lorenzo F. Sempere, PhD -- Dartmouth Medical School, Hanover, NH &

Dartmouth-Hitchcock Medical Center, Lebanon, NH

Laurie and Paul MacCaskill - Pancreatic Cancer Action Network - AACR

Career Development Award

Role of MicroRNAs in Initiation and Progression of Pancreatic Cancer

Peter Storz, PhD -- Mayo Clinic, Jacksonville, FL

Patty Boshell - Pancreatic Cancer Action Network - AACR Career

Development Award

Kinase Regulating Pancreatic Cancer Resistance to Chemotherapeutics

Pilot Grants: Two-year grants totaling $100,000 per award that support innovative research in pancreatic cancer.

Nabeel Bardeesy, PhD -- Massachusetts General Hospital, Boston

Randy Pausch, PhD - Pancreatic Cancer Action Network - AACR Pilot

Grant

Molecular Markers of Drug Sensitivity in Pancreatic Cancer

Dafna Bar-Sagi, PhD -- New York University School of Medicine,

New York

Pancreatic Cancer Action Network - AACR Pilot Grant

Impact of Diet-Induced Hyperlipidemia on Pancreatic Inflammation and

Cancer

Matthias Hebrok, PhD -- University of California, San Francisco

Michael C. Sandler - Pancreatic Cancer Action Network - AACR Pilot

Grant

NF-kB Signaling in PanIN Formation

Bin Liu, PhD -- University of California, San Francisco

Pancreatic Cancer Action Network - AACR Pilot Grant

Internalizing Human Antibodies Targeting Pancreatic Tumor Cells in

Situ

The research supported by these funds provides hope to the pancreatic cancer community and comes at a time of increased momentum by the Pancreatic Cancer Action Network to raise federal and private dollars to speed the discovery of a cure for pancreatic cancer. In January 2008, the organization launched Raise the Cure, an unprecedented initiative to secure $170 million in federal funding to carry out The National Plan to Advance Pancreatic Cancer Research and a commitment to raise $25 million in private funding.

To learn more about the Pancreatic Cancer Action Network, visit http://www.pancan.org.

About the Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network is the only national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organization raises money for direct private funding of research -- and advocates for more aggressive federal research funding of medical breakthroughs in prevention, diagnosis and treatment of pancreatic cancer.

The Pancreatic Cancer Action Network fills the void of information and options by giving patients and caregivers reliable, personalized information they need to make informed decisions. We create a sense of hope and community so no one has to face pancreatic cancer alone. The organization helps support individuals and communities all across the country work together to raise awareness and funds to find a cure for pancreatic cancer.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Julie Fleshman http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=75525


'/>"/>
SOURCE The Pancreatic Cancer Action Network
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cancer stem cell subpopulation drives metastasis of human pancreatic cancer
2. Chemotherapy with gemcitabine delays progression of operable pancreatic cancer
3. Jefferson scientists find protein may be key in developing deadly form of pancreatic cancer
4. Protein Gives Clues to Pancreatic Cancer
5. The most important candidate genes for pancreatic stone formation
6. Jefferson scientists find protein helps pancreatic cancer cells evade immune system and spread
7. Elusive pancreatic progenitor cells found in mice
8. Pancreatic cancer: The smaller the tumor, the better your chances, study shows
9. Treatment Combo for Pancreatic Cancer Has Limited Benefit
10. Patrick Swayzes Diagnosis With Pancreatic Cancer: a Statement From the Pancreatic Cancer Action Network
11. Karmanos Researchers Report Enhanced Chemosensitivity of Pancreatic Cancer Cells by Black Seed Component
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... Getting enough sleep affects much more than energy – it also has mental and physical ... compromise motor reaction time, which can increase the risk of having a car accident. ... from the NSF to help you sleep better and feel better:, , ...
(Date:4/28/2017)... California (PRWEB) , ... April 28, 2017 , ... ... T8 Direct Replace tubes . These lamps offer an instant energy-saving solution for ... need to rewire fixtures or disconnect ballasts. These 50,000 hour rated lamps utilize ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... been previously exposed to more adverse experiences than children in the general population. ... such as abuse, neglect or other family challenges. While no fault of their ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... hERG liability could substantially improve drug safety and minimize the cost of development. ... validating ion channel inhibition using cell lines and for cardiac toxicity using induced ...
(Date:4/28/2017)... ... ... Pastor and Overseer at The House of Yahweh in Abilene, Texas, has published a new ... not. Yisrayl says with so many titles and names for the Creator, it’s hard ... a little Scripture, backed with a lot of research, the truth is undeniable. , ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ... their offering. ... for drug delivery technologies will rise from USD 20 Billion in ... Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding ...
(Date:4/20/2017)... , April 20, 2017 Research ... Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, Growth ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 ... Mn by 2024, expanding at a CAGR of 5.6% from ...
(Date:4/19/2017)... Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it ... 2017 at the Sheraton Hotel in Toronto, Ontario ... the Company is scheduled to present on Tuesday, May 2 at ... Chairman of the Board, Tony Holler will also attend ... For more details ...
Breaking Medicine Technology: